Regarding prostate cancer, isoflavones, in addition to affecting the estrogen receptor, also modulate the androgen receptor, resulting in a decreased risk of the carcinogenesis process, but the detailed signalling pathways are still unknown [5]. This evidence concerns the gene ESR1 and Familial prostate cancer.